Down-regulation of the peroxisome proliferator-activated receptor (PPAR) gamma involved in the regulation of fatty acid metabolism and inflammation, has been demonstrated in IBD and is associated with maintenance of defensin expression [23]–[25]. Here, PPARG is linked to inflammatory bowel disease.